Miguel‐Teodoro Hernández

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study

Laura Rosiñol, Albert Oriol, Ana Isabel Teruel et al. · Blood · 2012 · 485 citations · Full text

Medicine, Hematology, Pharmacology +14

Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials

Juan José Lahuerta, Bruno Paiva, María‐Belén Vídriales et al. · Journal of Clinical Oncology · 2017 · 318 citations · Full text

Medicine, Hematology, Oncology +17

High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma

Bruno Paiva, Norma C. Gutiérrez, Laura Rosiñol et al. · Blood · 2011 · 304 citations · Full text

Medicine, Hematology, Oncology +17

A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma

Laura Rosiñol, José Antonio Pérez‐Simón, Anna Sureda et al. · Blood · 2008 · 264 citations · Full text

Medicine, Hematology, Oncology +15

Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis

María Eugenia Sarasquete, Ramón García‐Sánz, Miguel Alcoceba et al. · Blood · 2008 · 236 citations · Full text

Medicine, Genetics, Pharmacology +17